Haemonetics (HAE) Divestments (2017 - 2024)

Haemonetics (HAE) posted quarterly Divestments of $1.5 million for Q1 2024, down 85.9% quarter-over-quarter from $10.6 million in Q1 2022.

Haemonetics (HAE) Divestments (2017 - 2024) Analysis & Trends

Haemonetics' Divestments history runs 5 years deep, the most recent figure standing at $1.5 million for Q1 2024.

In Q1 2024, Divestments changed N/A year-over-year to $1.5 million; the TTM figure through Mar 2024 stood at $1.5 million (down 85.9% YoY), while the FY2025 annual figure was $43.3 million, up 2786.07% from the prior year.
Divestments for Q1 2024 stood at $1.5 million, down from $10.6 million in the prior quarter.
The five-year high for Divestments was $45.0 million in Q3 2020, with the low at -$391000.0 in Q4 2020.
The 3-year median for Divestments is $6.1 million (2022), against an average of $14.2 million.
Peak annual rise in Divestments reached 2821.74% in 2022, while the deepest fall reached 2821.74% in 2022.
Haemonetics' Divestments stood at -$391000.0 in 2020, then soared by 2821.74% to $10.6 million in 2022, then sank by 85.9% to $1.5 million in 2024.
Business Quant data shows HAE's Divestments at $1.5 million in Q1 2024, $10.6 million in Q1 2022, and -$391000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Abbott Laboratories	199.70 Bn	194.09 Bn	7.27 Bn	-
2	Stryker	129.93 Bn	126.46 Bn	4.50 Bn	-
3	Medtronic	120.49 Bn	111.27 Bn	6.41 Bn	-
4	Boston Scientific	74.60 Bn	74.06 Bn	3.85 Bn	-
5	Edwards Lifesciences	52.68 Bn	48.42 Bn	1.35 Bn	-
6	Dexcom	34.78 Bn	32.84 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn	-
8	Koninklijke Philips	26.44 Bn	23.12 Bn	4.55 Bn	153.43 Mn
9	Steris	23.18 Bn	22.69 Bn	684.20 Mn	-
10	Haemonetics	4.93 Bn	4.70 Bn	202.80 Mn	-

Download Data